EverSource Wealth Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

EverSource Wealth Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7	Closed	-$21	–	4208
2024 Q4	$21	Buy	+7	New	+$30	﹤0.01%	3710

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors's RVNC Position: Q1 2025 in Review

EverSource Wealth Advisors sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 7 shares — an estimated $21 sold.

EverSource Wealth Advisors first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $21 in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

EverSource Wealth Advisors reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
EverSource Wealth Advisors sold 7 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $21.
EverSource Wealth Advisors first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
EverSource Wealth Advisors's Revance Therapeutics, Inc. position peaked at $21 in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on EverSource Wealth Advisors's 13F filing for Q1 2025, filed 13 May 2025.